Doxazosin Mesylate
Rank #467 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$15.7M
Total Cost
729,878
Total Claims
$15.7M
Total Cost
24,364
Prescribers
$22
Cost per Claim
96,089
Beneficiaries
1,630,316
30-Day Fills
$645
Avg Cost/Provider
30
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$15.7M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $15.7M total
Top Prescribers of Doxazosin Mesylate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Hector Colombany Lorenzo | Cardiology | Aguadilla, PR | 2,343 | $27K |
| 2 | Carlos Muniz Molinero | Internal Medicine | Aguada, PR | 1,806 | $22K |
| 3 | Robert Morton | Psychiatry | Ada, OK | 845 | $19K |
| 4 | Kenneth Wong | Cardiology | Raceland, LA | 884 | $19K |
| 5 | William Sim | Internal Medicine | Downey, CA | 612 | $17K |
| 6 | Lance Sullenberger | Cardiology | Albany, NY | 513 | $15K |
| 7 | Mark Byron | Urology | Jesup, GA | 776 | $15K |
| 8 | Jamil Abouelhossen | Internal Medicine | Fajardo, PR | 724 | $15K |
| 9 | Rajesh Agarwal | Internal Medicine | Mayfield Heights, OH | 719 | $15K |
| 10 | Jose Padilla | Cardiology | San Juan, PR | 439 | $15K |
| 11 | Marwan Salfity | Cardiology | Omaha, NE | 680 | $15K |
| 12 | Douglas Welsh | Interventional Cardiology | Norfolk, NE | 457 | $14K |
| 13 | Tao Duong | Cardiology | Westminster, CA | 230 | $14K |
| 14 | Miguel Rodriguez Burgos | Cardiology | Juncos, PR | 758 | $12K |
| 15 | Anna Milstein | Cardiology | Los Angeles, CA | 545 | $11K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 464 | Hydrocortisone (Hydrocortisone) | $15.9M | 762,398 |
| 465 | Digoxin (Digoxin) | $15.9M | 548,410 |
| 466 | Alpelisib (Piqray) | $15.7M | 747 |
| 467 | Doxazosin Mesylate (Doxazosin Mesylate) | $15.7M | 729,878 |
| 468 | Prucalopride Succinate (Motegrity) | $15.7M | 22,068 |
| 469 | Ketorolac Tromethamine (Ketorolac Tromethamine) | $15.6M | 582,750 |
| 470 | Tetrabenazine (Tetrabenazine) | $15.6M | 6,326 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology